Thalidomide

Treating young patients with myeloma 2:22
Treating young patients with myeloma
Michele Cavo • 6 Mar 2021
Recommendations for the management of myeloma 3:26
Recommendations for the management of myeloma
Michel Delforge • 10 Mar 2021
Auto-allo tandem SCT for myeloma 0:45
Auto-allo tandem SCT for myeloma
Nicolaus Kröger • 4 Mar 2021
Dara plus IRd treatment for newly-diagnosed myeloma 4:22
Dara plus IRd treatment for newly-diagnosed myeloma
Morie Gertz • 2 Dec 2020
Quality of life in myeloma patients on carfilzomib-based therapy 7:43
Quality of life in myeloma patients on carfilzomib-based therapy
Heinz Ludwig • 26 Nov 2020
Treatment approaches for ASCT-eligible myeloma patients in the frontline 3:01
Treatment approaches for ASCT-eligible myeloma patients in the frontline
Mohamad Mohty • 1 Sep 2020
New developments in maintenance therapy for multiple myeloma 5:11
New developments in maintenance therapy for multiple myeloma
Graham Jackson • 2 Oct 2020
The evolving role of IMiDs 5:36
The evolving role of IMiDs
Xavier Leleu • 30 Sep 2020
The impact of CHIP expression on multiple myeloma treatment 3:24
The impact of CHIP expression on multiple myeloma treatment
Irene Ghobrial • 1 Oct 2020
PET/CT in multiple myeloma monitoring 2:14
PET/CT in multiple myeloma monitoring
Aurore Perrot • 31 Aug 2020
CASSIOPEIA: D-VTD in high-risk multiple myeloma 2:51
CASSIOPEIA: D-VTD in high-risk multiple myeloma
Aurore Perrot • 31 Aug 2020
Induction and front-line therapy for myeloma 3:59
Induction and front-line therapy for myeloma
Maria-Victoria Mateos • 25 Aug 2020
Retrospective analysis of lenalidomide and thalidomide in myelofibrosis 3:21
Retrospective analysis of lenalidomide and thalidomide in myelofibrosis
Andrew Kuykendall • 25 Aug 2020
Future JAK inhibitor combination approaches in myelofibrosis 3:51
Future JAK inhibitor combination approaches in myelofibrosis
Andrew Kuykendall • 25 Aug 2020
Managing myeloma during COVID-19: German perspective 4:41
Managing myeloma during COVID-19: German perspective
Katja Weisel • 31 May 2020
TOURMALINE-AL1: ixazomib for AL amyloidosis 3:36
TOURMALINE-AL1: ixazomib for AL amyloidosis
Angela Dispenzieri • 31 May 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals